Infectious Diseases
News
HIV vaccine trial makes pivotal leap toward making ‘super antibodies’
“The trial results show that one can design vaccines that induce antibodies with prespecified genetic features, and this may herald a new era of...
News
As COVID treatments dwindle, are new ones waiting in the wings?
Bebtelovimab couldn’t neutralize the Omicron subvariants BQ.1 and BQ.1.1.
News
Direct-acting antivirals tied to better outcomes in chronic Hep C
Researchers saw a significant reduction in all-cause mortality over a decade with direct-acting antivirals compared with no treatment.
Commentary
How a cheap liver drug may be the key to preventing COVID
The authors of a paper appearing in Nature give us multiple, complementary lines of evidence.
News
FDA pulls U.S. authorization for Eli Lilly’s COVID drug bebtelovimab
The drug is not expected to neutralize the dominant BQ.1 and BQ.1.1 subvariants of Omicron.
News
Buzzy Lancet long COVID paper under investigation for ‘data errors’
A reader found inconsistencies between the data in the article and a later paper describing the same cohort of patients after a year of follow-up...
News
Study finds chronic jet lag–like body clocks in people with HIV
The mistimed circadian phase in people living with HIV is linked to later sleep onset and earlier waking and has “important potential implications...
Conference Coverage
PrEP education during STI testing could boost HIV protection
It comes down to numbers. More people seek screening for STIs compared with those who actively seek PrEP for HIV prevention.
News
More vaccinated people dying of COVID as fewer get booster shots
But the case for the effectiveness of vaccines and boosters versus skipping the shots remains strong.
Conference Coverage
Study supports banning probiotics from the ICU
The risk is particularly acute for powdered formulations, presumably because powder more easily disseminates to contaminate central venous...